PITTSBURGH, PA – Starting today, PANTHERx Specialty now stocks the recently FDA-approved single dose vial of Makena (hydroxyprogesterone caproate injection).  Makena is the only FDA-approved treatment indicated to reduce the risk of preterm birth in women who are pregnant with one baby and who have spontaneously delivered one preterm baby in the past. 

Referral forms for both the single-dose and multi-dose vials are available here

For more information, please contact PANTHERx Specialty at 855-726-8479.